BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25620367)

  • 21. A novel membrane-disruptive antimicrobial peptide from frog skin secretion against cystic fibrosis isolates and evaluation of anti-MRSA effect using Galleria mellonella model.
    Yuan Y; Zai Y; Xi X; Ma C; Wang L; Zhou M; Shaw C; Chen T
    Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):849-856. PubMed ID: 30802593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates.
    Vidaillac C; Leonard SN; Rybak MJ
    Int J Antimicrob Agents; 2010 Jun; 35(6):527-30. PubMed ID: 20346632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro time-kill analysis of oritavancin against clinical isolates of methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin.
    Vidaillac C; Parra-Ruiz J; Rybak MJ
    Diagn Microbiol Infect Dis; 2011 Dec; 71(4):470-3. PubMed ID: 22018937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial activities of Bacillus velezensis strains isolated from stingless bee products against methicillin-resistant Staphylococcus aureus.
    Baharudin MMA; Ngalimat MS; Mohd Shariff F; Balia Yusof ZN; Karim M; Baharum SN; Sabri S
    PLoS One; 2021; 16(5):e0251514. PubMed ID: 33974665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective Antimicrobial Activity of Plectasin-Derived Antimicrobial Peptides against
    Li L; Wang L; Gao Y; Wang J; Zhao X
    Front Microbiol; 2017; 8():2386. PubMed ID: 29255451
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1.
    Jun SY; Jung GM; Yoon SJ; Oh MD; Choi YJ; Lee WJ; Kong JC; Seol JG; Kang SH
    Int J Antimicrob Agents; 2013 Feb; 41(2):156-61. PubMed ID: 23276502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial Activity of Different Antimicrobial Peptides (AMPs) Against Clinical Methicillin-resistant Staphylococcus aureus (MRSA).
    Ciandrini E; Morroni G; Arzeni D; Kamysz W; Neubauer D; Kamysz E; Cirioni O; Brescini L; Baffone W; Campana R
    Curr Top Med Chem; 2018; 18(24):2116-2126. PubMed ID: 30345920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1376-83. PubMed ID: 16569855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo efficacy and synergistic interaction of 16α-hydroxycleroda-3, 13 (14) Z-dien-15, 16-olide, a clerodane diterpene from Polyalthia longifolia against methicillin-resistant Staphylococcus aureus.
    Gupta VK; Verma S; Pal A; Srivastava SK; Srivastava PK; Darokar MP
    Appl Microbiol Biotechnol; 2013 Oct; 97(20):9121-31. PubMed ID: 23989974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.
    Yang N; Teng D; Mao R; Hao Y; Wang X; Wang Z; Wang X; Wang J
    Appl Microbiol Biotechnol; 2019 Jul; 103(13):5193-5213. PubMed ID: 31025073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
    Fritsche TR; Rhomberg PR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional structure and antimicrobial activity of persulcatusin, an antimicrobial peptide from the hard tick Ixodes persulcatus.
    Miyoshi N; Saito T; Ohmura T; Kuroda K; Suita K; Ihara K; Isogai E
    Parasit Vectors; 2016 Feb; 9():85. PubMed ID: 26873587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of action of a novel recombinant peptide, MP1102, against Clostridium perfringens type C.
    Zong L; Teng D; Wang X; Mao R; Yang N; Hao Y; Wang J
    Appl Microbiol Biotechnol; 2016 Jun; 100(11):5045-57. PubMed ID: 26921181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Infectivity-resistotype-genotype clustering of methicillin-resistant Staphylococcus aureus strains in the Central Blacksea Region of Turkey].
    Kırca Yılmaz S; Acuner IC; Strommenger B; Bek Y; Witte W
    Mikrobiyol Bul; 2014 Jan; 48(1):14-27. PubMed ID: 24506712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and pharmacodynamics of recombinant NZ2114 histidine mutants with improved activity against methicillin-resistant Staphylococcus aureus.
    Chen H; Mao R; Teng D; Wang X; Hao Y; Feng X; Wang J
    AMB Express; 2017 Dec; 7(1):46. PubMed ID: 28229435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin MIC susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates: a comparison between Etest® and an automated testing method.
    Bland CM; Porr WH; Davis KA; Mansell KB
    South Med J; 2010 Nov; 103(11):1124-8. PubMed ID: 20890258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
    Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
    Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of human and animal cathelicidins against livestock-associated methicillin-resistant Staphylococcus aureus.
    Blodkamp S; Kadlec K; Gutsmann T; Naim HY; von Köckritz-Blickwede M; Schwarz S
    Vet Microbiol; 2016 Oct; 194():107-111. PubMed ID: 26453316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Miniature Membrane Active Lipopeptidomimetics against Planktonic and Biofilm Embedded Methicillin-Resistant Staphylococcus aureus.
    Joshi S; Mumtaz S; Singh J; Pasha S; Mukhopadhyay K
    Sci Rep; 2018 Jan; 8(1):1021. PubMed ID: 29348589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.